[Ip-health] restrictions to pharmaceutical patentability

Ken Shadlen k.shadlen at lse.ac.uk
Sun Jan 1 06:07:53 PST 2012

I am looking to see if anyone has extended or updated Sisule Musungu and Cecilia Oh's  2006 WHO survey of the use of TRIPS flexibilities (http://www.who.int/intellectualproperty/studies/TRIPS_flexibilities/en/index.html), in particular the material on restrictions to patentability in pharmaceuticals. If anyone has done work in this regard, or know of others who have, please let me know.


Ken Shadlen
Reader, Department of International Development
London School of Economics 
London WC2A 2AE (United Kingdom)

TEL: +(44-20) 7852-3681
FAX: +(44-20) 7955-6844
EMAIL: k.shadlen at lse.ac.uk

Personal homepage: http://personal.lse.ac.uk/shadlen
Journal of Development Studies: http://www.tandf.co.uk/journals/jds

Please access the attached hyperlink for an important electronic communications disclaimer: http://lse.ac.uk/emailDisclaimer

More information about the Ip-health mailing list